Anna Sussman | Vice President-Investor Relations and Corporate Communications |
Patrick Mahaffy | President and Chief Executive Officer |
Thomas Harding | Chief Scientific Officer |
Lindsey Rolfe | Chief Medical Officer |
Dan Muehl | Chief Financial Officer |
Charlie Ferranti | Goldman Sachs |
Gavin Scott | JPMorgan |
Good morning. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Clovis Oncology Fourth Quarter and Year End 2021 Operating Results. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session.